NCT Number: NCT07739693
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by difficulties in social communication and interaction, as well as impairments in physical function domains such as postural control, balance, coordination, and motor planning. This study is designed as a randomized controlled trial to determine the effects of hippotherapy, applied in addition to a special education program, on physical function, bladder-bowel symptoms, and social communication level in children with ASD.
Trial opening soon.
Get Notified7 year–15 year
All sexes
Interventional
Not applicable
Ankara, Turkey (Türkiye)
Elif Sena Dusgun, PhD
SUB_INVESTIGATOR
General Secretariat
CONTACT
Rumeysa Karayel, BSc
SUB_INVESTIGATOR
Seyda Toprak Celenay, PhD
PRINCIPAL_INVESTIGATOR
Tugba Kilickaya, BSc
SUB_INVESTIGATOR
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social communication and interaction, along with restricted and repetitive patterns of behavior.
During hippotherapy, the child must continuously make postural adjustments to adapt to the rhythmic movements of the horse. The literature has demonstrated that hippotherapy has positive effects on balance, postural control, functional independence, and motor performance, particularly in children with cerebral palsy and Down syndrome.
However, evidence regarding the effects of hippotherapy in children with ASD remains limited, particularly in relation to physical function, bladder and bowel symptoms, and social communication. Therefore, the present study aims to investigate the effects of hippotherapy on physical function-including balance, trunk control, posture, and handgrip strength-as well as bladder and bowel symptoms and social communication in children with ASD. By addressing this gap in the literature, the findings of the study may contribute to the existing evidence and provide guidance for rehabilitation practices.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Diagnosed with autism spectrum disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
Able to understand and follow basic verbal instructions. Able to stand independently for at least 30 seconds. Voluntary participation in the study and written informed consent obtained from a parent or legal guardian.
Exclusion criteria
Presence of an active infection. Bladder or bowel symptoms attributable to an organic condition, such as anorectal malformation or Hirschsprung disease.
Presence of another neurological or orthopedic condition that may affect participation or outcomes, such as cerebral palsy or hip dislocation.
Inability to attend the treatment program regularly. Receipt of hippotherapy within the previous 12 months. History of epilepsy or seizures. History of surgery involving the spine and/or abdominopelvic region within the previous 12 months.
Participants will receive 30-minute hippotherapy sessions once weekly for 8 weeks in addition to their ongoing special education program. The program will include exercises targeting balance, postural control, trunk stabilization, coordination, muscle strength, upper extremity function, and sensory processing.
Participants will continue their ongoing special education program throughout the 8-week study period. The program includes educational activities, speech and language therapy, occupational therapy, proprioceptive activities, and sensory-based interventions according to the individual needs of the child.
Time frame: Baseline and at the end of the 8-week intervention
Balance will be assessed using the Pediatric Balance Scale, a 14-item scale evaluating sitting balance, standing balance, transfers, reaching, turning, and stepping activities. The total score ranges from 0 to 56, with higher scores indicating better balance performance. The scale will be administered by a physiotherapist.
Time frame: Baseline and at the end of the 8-week intervention
Trunk control will be assessed using the Trunk Control Measurement Scale. The total score ranges from 0 to 58, with higher scores indicating better trunk control. The assessment will be administered by a physiotherapist.
Time frame: Baseline and at the end of the 8-week intervention
Postural alignment will be assessed using the New York Posture Rating Chart. The total score ranges from 13 to 65, with higher scores indicating better postural alignment. The assessment will be performed by a physiotherapist.
Time frame: Baseline and at the end of the 8-week intervention
Handgrip strength will be measured in kilograms using a hand dynamometer. Three measurements will be obtained for each hand, with a 1-minute rest period between measurements. The mean value of the three measurements will be used in the analysis. Higher values indicate greater handgrip strength.
Time frame: Baseline and at the end of the 8-week intervention
Bladder and bowel symptoms will be assessed using the Bladder and Bowel Dysfunction Questionnaire. The total score ranges from 0 to 52, with higher scores indicating greater symptom severity. The questionnaire will be completed by the child with parental assistance.
Time frame: Baseline and at the end of the 8-week intervention
Social communication will be assessed using the Autism Social Skills Profile-Turkish Form. The scale consists of 45 items and includes three subscales: social reciprocity, social participation/avoidance, and detrimental social behaviors. Items are rated on a 4-point Likert scale. Higher total scores indicate better social skills. The questionnaire will be completed by the participant's parent.
Contact information is provided by the study sponsor or research team.
Fenerbahce University
Other
THE EFFECTS OF HIPPOTHERAPY ON PHYSICAL FUNCTION, BLADDER AND BOWEL SYMPTOMS, AND SOCIAL COMMUNICATION IN CHILDREN WITH AUTISM SPECTRUM DISORDER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07546942
Autism, Autism Spectral Disorder
Hamilton, Montana, United States
View Trial DetailsNCT07494513
Autism, Autism Spectrum Disorder
Omaha, Nebraska, United States
View Trial DetailsNCT06253793
Autism Spectrum Disorder, Behavior
Saint-Égrève, Isere, France
View Trial DetailsNCT05889273
Autism Spectrum Disorder, Autistic Disorder
Dothan, Alabama, United States
View Trial Details